{"id":"gm-csf-and-g-csf","safety":{"commonSideEffects":[{"rate":"25-50","effect":"Bone pain"},{"rate":"10-30","effect":"Fever"},{"rate":"10-20","effect":"Fatigue"},{"rate":"5-15","effect":"Headache"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"5-10","effect":"Splenomegaly"}]},"_chembl":{"chemblId":"CHEMBL2108239","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) are hematopoietic growth factors that bind to their respective receptors on myeloid progenitor cells, promoting their expansion, maturation, and functional activation. These cytokines enhance neutrophil and monocyte production, improving immune function and reducing infection risk in immunocompromised patients.","oneSentence":"GM-CSF and G-CSF are cytokines that stimulate the proliferation and differentiation of granulocytes and monocytes from bone marrow progenitor cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:58.785Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chemotherapy-induced neutropenia"},{"name":"Bone marrow transplantation support"},{"name":"Severe chronic neutropenia"},{"name":"Mobilization of peripheral blood progenitor cells"}]},"trialDetails":[{"nctId":"NCT07437963","phase":"PHASE1, PHASE2","title":"Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-05-01","conditions":"Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma, Refractory Ganglioneuroblastoma","enrollment":76},{"nctId":"NCT05269381","phase":"PHASE1, PHASE2","title":"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-03-31","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8","enrollment":132},{"nctId":"NCT03909412","phase":"PHASE1","title":"Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2019-10-08","conditions":"Multiple Myeloma","enrollment":18},{"nctId":"NCT06517641","phase":"PHASE2","title":"Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia","status":"RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2025-05-12","conditions":"Severe Aplastic Anemia","enrollment":60},{"nctId":"NCT01391962","phase":"PHASE2","title":"Sunitinib or Cediranib for Alveolar Soft Part Sarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-07-18","conditions":"Sarcoma, Alveolar Soft Part","enrollment":34},{"nctId":"NCT01871766","phase":"PHASE2","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-12-04","conditions":"Rhabdomyosarcoma","enrollment":115},{"nctId":"NCT01857934","phase":"PHASE2","title":"Therapy for Children With Advanced Stage Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-07-05","conditions":"Neuroblastoma","enrollment":153},{"nctId":"NCT03125642","phase":"PHASE2","title":"Auto Stem Cell Transplant for Lymphoma Patients","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2017-04-20","conditions":"Non-Hodgkin Lymphoma, Hodgkin Lymphoma","enrollment":150},{"nctId":"NCT04237623","phase":"PHASE2","title":"GM-CSF With Post-Transplant Cyclophosphamide","status":"RECRUITING","sponsor":"Northside Hospital, Inc.","startDate":"2020-05-18","conditions":"Transplant-Related Hematologic Malignancy","enrollment":38},{"nctId":"NCT03396575","phase":"PHASE1","title":"Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-07-17","conditions":"Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma","enrollment":11},{"nctId":"NCT03630211","phase":"PHASE2","title":"Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2018-07-31","conditions":"Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease","enrollment":8},{"nctId":"NCT06418295","phase":"","title":"Cytokine Alterations and Chronic Post-Surgical Pain","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-01","conditions":"Chronic Post Operative Pain","enrollment":60},{"nctId":"NCT06757348","phase":"","title":"Fatty Liver and Pancreatic Steatosis","status":"NOT_YET_RECRUITING","sponsor":"Maria Marta Piskorz","startDate":"2025-09-01","conditions":"Exocrine Pancreatic Insufficiency, Fatty Liver, Nonalcoholic, Pancreatic Steatosis","enrollment":61},{"nctId":"NCT00646763","phase":"PHASE2","title":"A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation","status":"TERMINATED","sponsor":"Emory University","startDate":"2008-04","conditions":"Cytokines","enrollment":35},{"nctId":"NCT03150004","phase":"PHASE2","title":"Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients with Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2017-06-14","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":53},{"nctId":"NCT04447469","phase":"PHASE2, PHASE3","title":"Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation","status":"COMPLETED","sponsor":"Kiniksa Pharmaceuticals International, plc","startDate":"2020-07-28","conditions":"COVID","enrollment":814},{"nctId":"NCT03441048","phase":"PHASE1","title":"Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2018-05-22","conditions":"Acute Myeloid Leukemia","enrollment":26},{"nctId":"NCT04560166","phase":"PHASE2","title":"Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma","status":"TERMINATED","sponsor":"Y-mAbs Therapeutics","startDate":"2021-11-08","conditions":"Neuroblastoma Recurrent","enrollment":2},{"nctId":"NCT00630565","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-07-26","conditions":"Leukemia","enrollment":12},{"nctId":"NCT00571662","phase":"PHASE2","title":"Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2000-12-08","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":76},{"nctId":"NCT00046930","phase":"PHASE3","title":"Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2002-09-17","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":449},{"nctId":"NCT05330377","phase":"PHASE1","title":"GM-CLAG in Relapsed/Refractory FLT3-mutated AML","status":"WITHDRAWN","sponsor":"Ayman H Qasrawi","startDate":"2023-03","conditions":"Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT00005835","phase":"PHASE1","title":"N99-02: Melphalan and Buthionine Sulfoximine","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2001-08","conditions":"Neuroblastoma","enrollment":31},{"nctId":"NCT04584112","phase":"PHASE1","title":"A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2020-09-28","conditions":"Triple-Negative Breast Cancer","enrollment":83},{"nctId":"NCT02593123","phase":"PHASE2","title":"Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2015-11-04","conditions":"Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma","enrollment":31},{"nctId":"NCT00096460","phase":"PHASE2, PHASE3","title":"Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)","status":"TERMINATED","sponsor":"Medical College of Wisconsin","startDate":"2004-08","conditions":"Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma","enrollment":30},{"nctId":"NCT02918292","phase":"PHASE2","title":"Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2017-07-03","conditions":"Severe Aplastic Anemia","enrollment":32},{"nctId":"NCT04104594","phase":"NA","title":"Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2020-02-05","conditions":"Nasal Polyps, Chronic Rhinosinusitis With Nasal Polyps, Olfaction Disorders","enrollment":3},{"nctId":"NCT01319981","phase":"PHASE2","title":"Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-03-05","conditions":"Leukemia","enrollment":31},{"nctId":"NCT05451420","phase":"NA","title":"Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy","status":"COMPLETED","sponsor":"Henan Provincial People's Hospital","startDate":"2017-12-01","conditions":"Chronic Hepatitis B","enrollment":33},{"nctId":"NCT00000896","phase":"NA","title":"A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT03018223","phase":"PHASE1","title":"Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2017-01-31","conditions":"Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia","enrollment":32},{"nctId":"NCT01685411","phase":"NA","title":"Busulfan and Cyclophosphamide Followed By ALLO BMT","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2013-01","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":5},{"nctId":"NCT01045460","phase":"PHASE2","title":"Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2010-01-15","conditions":"Multiple Myeloma","enrollment":36},{"nctId":"NCT00671658","phase":"PHASE2","title":"Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-11","conditions":"Leukemia, Acute Lymphoblastic Leukemia","enrollment":220},{"nctId":"NCT00290433","phase":"PHASE2","title":"Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2003-09","conditions":"Lymphoma","enrollment":55},{"nctId":"NCT00345865","phase":"PHASE2","title":"Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-08-24","conditions":"Lymphoma","enrollment":473},{"nctId":"NCT01329900","phase":"PHASE2","title":"Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-08-22","conditions":"Lymphoma","enrollment":50},{"nctId":"NCT02786719","phase":"NA","title":"High-Risk Neuroblastoma Chemotherapy Without G-CSF","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2016-06","conditions":"Neuroblastoma","enrollment":13},{"nctId":"NCT01731886","phase":"PHASE4","title":"Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Columbia University","startDate":"2012-09","conditions":"Multiple Myeloma","enrollment":60},{"nctId":"NCT00582816","phase":"PHASE1, PHASE2","title":"Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2008-08","conditions":"Leukemia, Solid Tumors","enrollment":9},{"nctId":"NCT00003397","phase":"PHASE2","title":"Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"1998-09","conditions":"Lymphoma","enrollment":25},{"nctId":"NCT00003727","phase":"PHASE2","title":"Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"1999-03","conditions":"Leukemia","enrollment":22},{"nctId":"NCT00968253","phase":"PHASE1, PHASE2","title":"RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-11","conditions":"Leukemia, Acute Lymphocytic Leukemia","enrollment":24},{"nctId":"NCT00134082","phase":"PHASE1, PHASE2","title":"Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2005-11","conditions":"Lymphoma","enrollment":31},{"nctId":"NCT01576692","phase":"PHASE1","title":"Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-04","conditions":"Neuroblastoma","enrollment":34},{"nctId":"NCT02933333","phase":"PHASE4","title":"G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2016-09-27","conditions":"Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma","enrollment":405},{"nctId":"NCT03435900","phase":"PHASE2","title":"Intraperitoneal Administration of Fosfomycin, Metronidazole and Molgramostim Versus Intravenous Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Herlev Hospital","startDate":"2018-02-14","conditions":"Appendicitis Perforated","enrollment":13},{"nctId":"NCT00002461","phase":"PHASE2","title":"Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Montefiore Medical Center","startDate":"1988-04","conditions":"Lymphoma","enrollment":35},{"nctId":"NCT00064337","phase":"PHASE2","title":"S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2004-01","conditions":"Multiple Myeloma, Plasma Cell Myeloma","enrollment":104},{"nctId":"NCT00389818","phase":"PHASE2","title":"Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2007-01","conditions":"Lymphoma","enrollment":43},{"nctId":"NCT00669877","phase":"PHASE2","title":"Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2002-08","conditions":"Burkitt's Lymphoma, Burkitt'S-like Lymphoma","enrollment":56},{"nctId":"NCT00482053","phase":"PHASE2","title":"Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT","status":"TERMINATED","sponsor":"Stanford University","startDate":"2006-10","conditions":"Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL)","enrollment":3},{"nctId":"NCT00952237","phase":"PHASE1","title":"Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2003-01","conditions":"Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma","enrollment":13},{"nctId":"NCT00481832","phase":"PHASE2","title":"Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Stanford University","startDate":"2007-01","conditions":"Lymphoma, Non-Hodgkin","enrollment":50},{"nctId":"NCT00609739","phase":"PHASE1, PHASE2","title":"Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"1999-06","conditions":"Leukemia","enrollment":1},{"nctId":"NCT02130869","phase":"PHASE1","title":"A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-10-10","conditions":"Neuroblastoma, Lymphoma, High-risk Tumor","enrollment":8},{"nctId":"NCT00623077","phase":"PHASE1","title":"MT2004-30: Tomotherapy for Solid Tumors","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2005-08","conditions":"Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer","enrollment":23},{"nctId":"NCT00686556","phase":"PHASE1","title":"Total Marrow Irradiation for Refractory Acute Leukemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-08","conditions":"Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma","enrollment":12},{"nctId":"NCT00005987","phase":"PHASE2","title":"Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2000-08","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":87},{"nctId":"NCT00006184","phase":"PHASE2","title":"Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-02-08","conditions":"Multiple Myeloma","enrollment":20},{"nctId":"NCT00242996","phase":"PHASE2","title":"Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2004-03","conditions":"Lymphoma","enrollment":44},{"nctId":"NCT00228813","phase":"NA","title":"G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome","status":"TERMINATED","sponsor":"Emory University","startDate":"2004-04","conditions":"Hematologic Malignancies","enrollment":8},{"nctId":"NCT00088985","phase":"PHASE2","title":"Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2004-01","conditions":"Breast Cancer","enrollment":56},{"nctId":"NCT01158118","phase":"PHASE2","title":"Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2011-04-01","conditions":"Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Lymphoma, Non-Hodgkin","enrollment":48},{"nctId":"NCT00238173","phase":"PHASE1","title":"Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2004-12","conditions":"Bone Marrow Suppression, Brain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ","enrollment":2},{"nctId":"NCT00003119","phase":"PHASE3","title":"Surgery in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1998-03","conditions":"Neuroblastoma","enrollment":968},{"nctId":"NCT00002601","phase":"PHASE2","title":"Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"1994-09","conditions":"Sarcoma","enrollment":13},{"nctId":"NCT00002931","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"1997-02","conditions":"Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer","enrollment":48},{"nctId":"NCT00040937","phase":"PHASE2","title":"S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2002-06","conditions":"Multiple Myeloma","enrollment":147},{"nctId":"NCT00098774","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2004-10","conditions":"Lymphoma","enrollment":47},{"nctId":"NCT00546377","phase":"PHASE1, PHASE2","title":"Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2005-07","conditions":"Leukemia, Lymphoma","enrollment":50},{"nctId":"NCT01415713","phase":"PHASE1, PHASE2","title":"The Study of Metastatic Pancreatic Adenocarcinoma","status":"COMPLETED","sponsor":"National Health Research Institutes, Taiwan","startDate":"2012-03","conditions":"Metastatic Pancreatic Adenocarcinoma","enrollment":73},{"nctId":"NCT00521014","phase":"PHASE2","title":"GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-10","conditions":"Lymphoma","enrollment":14},{"nctId":"NCT00083551","phase":"PHASE3","title":"UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"1998-08","conditions":"Multiple Myeloma","enrollment":668},{"nctId":"NCT00038610","phase":"PHASE2","title":"Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-03","conditions":"Leukemia","enrollment":54},{"nctId":"NCT00446173","phase":"PHASE2","title":"Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-03","conditions":"Leukemia","enrollment":""},{"nctId":"NCT00022230","phase":"PHASE1, PHASE2","title":"Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer","status":"WITHDRAWN","sponsor":"Roger Williams Medical Center","startDate":"2000-01","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00023777","phase":"PHASE2","title":"S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2001-08","conditions":"Leukemia","enrollment":71},{"nctId":"NCT00004217","phase":"PHASE2","title":"S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2000-02","conditions":"Leukemia","enrollment":55},{"nctId":"NCT00003416","phase":"PHASE2","title":"S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1998-09","conditions":"Lymphoma","enrollment":9},{"nctId":"NCT00066794","phase":"PHASE2","title":"S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"2004-07","conditions":"Leukemia","enrollment":69},{"nctId":"NCT00073931","phase":"PHASE2","title":"Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-10","conditions":"Lymphoma","enrollment":25},{"nctId":"NCT00003093","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1988-03","conditions":"Neuroblastoma","enrollment":573},{"nctId":"NCT00256334","phase":"PHASE1","title":"Resveratrol for Patients With Colon Cancer","status":"COMPLETED","sponsor":"University of California, Irvine","startDate":"2005-07","conditions":"Colon Cancer, Cancer","enrollment":11},{"nctId":"NCT00580034","phase":"PHASE2","title":"Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath","status":"COMPLETED","sponsor":"David Rizzieri, MD","startDate":"2003-02","conditions":"Lymphoma, Myeloma, Leukemia","enrollment":176},{"nctId":"NCT00004135","phase":"PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"1999-02","conditions":"Kidney Cancer, Melanoma (Skin)","enrollment":19},{"nctId":"NCT00003955","phase":"PHASE2","title":"Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-09","conditions":"Sarcoma","enrollment":77},{"nctId":"NCT00002995","phase":"PHASE3","title":"Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1997-08","conditions":"Sarcoma","enrollment":483},{"nctId":"NCT00017368","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2001-04","conditions":"Neuroblastoma","enrollment":42},{"nctId":"NCT00003163","phase":"PHASE2","title":"Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers","status":"UNKNOWN","sponsor":"Medical College of Wisconsin","startDate":"1997-09","conditions":"Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":10},{"nctId":"NCT00002599","phase":"PHASE3","title":"Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma","status":"UNKNOWN","sponsor":"Medical Research Council","startDate":"1994-09","conditions":"Multiple Myeloma and Plasma Cell Neoplasm","enrollment":750},{"nctId":"NCT00499343","phase":"PHASE2","title":"G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2004-01","conditions":"Lymphoma","enrollment":84},{"nctId":"NCT00002638","phase":"PHASE2","title":"Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"1995-03","conditions":"Leukemia","enrollment":30},{"nctId":"NCT00002697","phase":"PHASE2","title":"Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1995-09","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT00003958","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2002-09","conditions":"Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma","enrollment":702},{"nctId":"NCT00003943","phase":"PHASE2","title":"Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.","status":"COMPLETED","sponsor":"Fox Chase Cancer Center","startDate":"1998-09","conditions":"Carcinoma of Unknown Primary, Lung Cancer","enrollment":3},{"nctId":"NCT00002552","phase":"PHASE2","title":"Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma","status":"COMPLETED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"1993-10","conditions":"Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":40},{"nctId":"NCT00014573","phase":"PHASE2","title":"Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer","status":"COMPLETED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"1998-08","conditions":"Brain and Central Nervous System Tumors","enrollment":""},{"nctId":"NCT00002784","phase":"PHASE3","title":"High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer","status":"COMPLETED","sponsor":"ETOP IBCSG Partners Foundation","startDate":"1996-06","conditions":"Breast Cancer","enrollment":344}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"GM-CSF and G-CSF","genericName":"GM-CSF and G-CSF","companyName":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","companyId":"xinhua-hospital-shanghai-jiao-tong-university-school-of-medicine","modality":"Biologic","firstApprovalDate":"","aiSummary":"GM-CSF and G-CSF are cytokines that stimulate the proliferation and differentiation of granulocytes and monocytes from bone marrow progenitor cells. Used for Chemotherapy-induced neutropenia, Bone marrow transplantation support, Severe chronic neutropenia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}